AF

Afya Limited

AFYAConsumer DefensiveNASDAQ

Education & Training Services · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.70B
+11.9% YoY
Net Income
$752.5M
+19.2% YoY
EBITDA
$1.67B
+21.6% YoY
Free Cash Flow
$525.2M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.0279, negative momentum
Jun 29 MACD Positive CrossoverHistogram +0.0709, positive momentum
About Afya Limited

Afya Limited operates as a medical education group in Brazil. Valued at $1.27B, AFYA is a small-cap name in its sector. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions.

Key stats
Market Cap$1.27B
P/E (TTM)8.80
Fwd P/E6.96
EPS$1.58
Beta0.35
52W Change-8.3%
Dividend Yield4.64%
ROE16.8%
Analysis

Afya Limited carries $3.20B in total debt against $1.33B in cash reserves — debt is roughly 2.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $525.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 16.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.33B (2022) to $3.70B (2025), reflecting a 59% increase over the period.

With a beta below 0.7, Afya Limited typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing AFYA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms